1. Home
  2. KOF vs DGX Comparison

KOF vs DGX Comparison

Compare KOF & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coca Cola Femsa S.A.B. de C.V.

KOF

Coca Cola Femsa S.A.B. de C.V.

N/A

Current Price

$118.40

Market Cap

23.1B

ML Signal

N/A

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

N/A

Current Price

$260.03

Market Cap

25.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOF
DGX
Founded
1979
1967
Country
Mexico
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.1B
25.9B
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
KOF
DGX
Price
$118.40
$260.03
Analyst Decision
Buy
Buy
Analyst Count
15
17
Target Price
$123.26
★ $257.27
AVG Volume (30 Days)
366.3K
★ 855.5K
Earning Date
10-26-2026
10-22-2026
Dividend Yield
★ 3.46%
1.33%
EPS Growth
N/A
★ 13.78
EPS
N/A
★ 7.86
Revenue
N/A
★ $11,035,000,000.00
Revenue This Year
N/A
$9.51
Revenue Next Year
$8.80
$4.45
P/E Ratio
★ $18.35
$32.86
Revenue Growth
N/A
★ 11.78
52 Week Low
$85.38
$171.18
52 Week High
$122.14
$260.29

Technical Indicators

Market Signals
Indicator
KOF
DGX
Relative Strength Index (RSI) 57.72 69.34
Support Level $103.90 $226.27
Resistance Level $122.14 N/A
Average True Range (ATR) 3.08 5.89
MACD 0.18 1.06
Stochastic Oscillator 71.44 90.81

Price Performance

Historical Comparison
KOF
DGX

About KOF Coca Cola Femsa S.A.B. de C.V.

Coca-Cola Femsa, a subsidiary of Femsa, is the largest franchise bottler of Coca-Cola in volume terms. The company purchases beverage concentrates and syrup from Coca-Cola, which it then processes and packages for distribution through modern trade, traditional trade, and the on-premises channel. Mexico and Brazil make up 80% of the total volume and sales, with the rest from other Central and South American countries, including Panama, Guatemala, Uruguay, and Argentina. Femsa and Coca-Cola hold 47% and 28% economic interests in Coca-Cola Femsa through nonpublicly traded A and D shares, respectively, while controlling 56% and 33% of the voting power.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: